Search results for "hypertrophic"

showing 10 items of 42 documents

Hypertrophic Lichen Planus: Importance of Follow-Up and Clinicopathologic Correlation

2021

Hypertrophic lichen planusClinicopathologic correlationmedicine.medical_specialtyHistologybusiness.industrymedicineMEDLINEDermatologybusinessDermatologyPathology and Forensic MedicineActas Dermo-Sifiliográficas (English Edition)
researchProduct

Cardiomyopathic lentiginosis: an echo-Doppler report

1995

We report a case of a 64-year-old woman with cardiomyopathic lentiginosis. All the echocardiographic features of a hypertrophic obstructive cardiomyopathy were detected, with an accurate noninvasive measure of the left ventricle outflow gradient.

Lentigomedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCardiomyopathyCardiomyopathy HypertrophicMiddle AgedDoppler echocardiographymedicine.diseaseLEOPARD SyndromeObstructive cardiomyopathyEchocardiography Dopplermedicine.anatomical_structureVentricleInternal medicinemedicineCardiologyHumansFemaleLentiginosisCardiology and Cardiovascular MedicinebusinessEcho dopplerInternational Journal of Cardiology
researchProduct

Hypertrophic pyloric stenosis masked by kidney failure in a male infant with a contiguous gene deletion syndrome at Xp22.31 involving the steroid sul…

2022

Abstract Background Contiguous gene deletion syndrome at Xp22.3 resulting in nullisomy in males or Turner syndrome patients typically encompasses the steroid sulfatase gene (STS) and contiguously located other genes expanding the phenotype. In large deletions, that encompass also the Kallmann syndrome 1 gene (KAL1), occasionally infantile hypertrophic pyloric stenosis (IHPS) and congenital anomalies of the kidney and urinary tract (CAKUT) have been reported. Patient presentation We report on a male newborn with family history in maternal uncle of renal abnormalities and short stature still without ichthyosiform dermatosis. The baby presented CAKUT with kidney failure and progressive vomitin…

MaleCongenital anomalies of the kidney and urinary tractInfantPyloric Stenosis HypertrophicCase ReportPediatricsRJ1-570Xp22.3 nullisomyGastric outlet obstructionCase report Congenital anomalies of the kidney and urinary tract Digestive system abnormalities Gastric outlet obstruction Gene Deletion Human Infant Male Pyloric Stenosis Hypertrophic Renal Insufficiency Steryl-Sulfatase Ultrasonography Xp22.3 nullisomyHumansDigestive system abnormalitiesSteryl-SulfataseRenal InsufficiencyGene DeletionUltrasonography
researchProduct

A rare case of hyperproliferative gastropathy.

2014

Gastroenterology and Endoscopy Unit, Fondazione Istituto S. Raffaele – G. Giglio, Cefalu, Italy PhD Course in Surgical Biotechnology and Regenerative Medicine, School of Medicine, University of Palermo, Italy Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy Pathology Unit, Fondazione Istituto S. Raffaele – G. Giglio, Cefalu, Italy Radiology Unit Fondazione Istituto S. Raffaele – G. Giglio, Cefalu, Italy

Malemedicine.medical_specialtyHepatologybusiness.industryGeneral surgeryStomachGastroenterologyRare caseGastroscopyMedicineHumansRadiology UnitbusinessGastritis HypertrophicAgedDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score

2019

Sudden cardiac death (SCD) is the most life-threating complication of hypertrophic cardiomyopathy. Guidelines of the European Society of Cardiology (ESC) suggest the implantation of an implantable cardioverter defibrillator in primary prevention according to a 5-year risk SCD score >= 6%. The aim of the study is to evaluate the prognostic role of late gadolinium enhancement (LGE) in patients with a 5-year risk SCD score <6%. In this multicenter study, we performed cardiac magnetic resonance in 354 consecutive hypertrophic cardiomy-opathy patients (257 males, range of age 54 +/- 17) with a risk SCD score <6% (302 with <4% and 52 with >= 4 and <6% risk). Hard cardiac events,…

Malemedicine.medical_treatmentLeftCardiomyopathyContrast MediaGadolinium030204 cardiovascular system & hematologyVentricular Function Left030218 nuclear medicine & medical imagingSudden cardiac death0302 clinical medicineRisk Factorshemic and lymphatic diseasesVentricular FunctionFramingham Risk Scoremedicine.diagnostic_testIncidenceHypertrophic cardiomyopathyMiddle AgedImplantable cardioverter-defibrillatorPrognosisMagnetic Resonance ImagingHypertrophic Cardiomyopathy Sudden Cardiac Death.DeathSurvival RateItalyCineCardiologyFemaleCardiology and Cardiovascular MedicineCardiaccongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyCardiomyopathyHeart VentriclesMagnetic Resonance Imaging CineRisk Assessment03 medical and health sciencesInternal medicinemedicineHumanscardiovascular diseasesRetrospective Studiesbusiness.industryMyocardiumMagnetic resonance imagingRetrospective cohort studyCardiomyopathy HypertrophicCardiomyopathy Hypertrophic; Contrast Media; Death Sudden Cardiac; Female; Follow-Up Studies; Gadolinium; Heart Ventricles; Humans; Incidence; Italy; Magnetic Resonance Imaging Cine; Male; Middle Aged; Myocardium; Prognosis; ROC Curve; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Ventricular Function Leftmedicine.diseaseSuddenSudden cardiac deathDeath Sudden CardiacROC CurveHypertrophicComplicationbusinessFollow-Up Studies
researchProduct

Oxidative Stress Markers in Hypertrophic Cardiomyopathy

2021

Background and Objectives: Hypertrophic cardiomyopathy (HCM) depends on the primary impairment of sarcomeres, but it can also be associated with secondary alterations in the heart related to oxidative stress. The present study aimed to examine oxidative-antioxidant disturbances in patients with HCM compared with control individuals. Materials and Methods: We enrolled 52 consecutive HCM patients and 97 controls without HCM. The groups were matched for age, body mass index, and sex. Peripheral blood was collected from all patients to determine the total antioxidant capacity (TAC), total oxidant status (TOS), lipid hydroperoxide (LPH), and malondialdehyde (MDA). The oxidative stress index (OSI…

Medicine (General)markersGeneral MedicineCardiomyopathy HypertrophicMiddle Agedhypertrophic cardiomyopathyOxidantsArticleAntioxidantsOxidative StressR5-920Malondialdehydeoxidative stress; markers; hypertrophic cardiomyopathyHumansFemalecardiovascular diseasesMedicina
researchProduct

Usefulness of DNA quantification in diagnosis of hypertrophic cardiomyopathies

2006

Hypertrophic cardiomyopathies (HCM) are a frequent cause of sudden death in both young people and adults. Different cardiomyopathies can be distinguished according to the etiological agent and, although there are morphological differences too, alterations in the quantity of DNA in the cardiomyocytes may play an important role in their pathogenesis and evolution. To understand the characteristics and the behaviour of the DNA index in hypertrophic cardiomyopathies, we have studied thirty cases (10 primaries or essential, 10 hypertensives and 10 toxic) and compared the results with those obtained for 10 macroscopically normal hearts. The results showed that the different cardiomyopathies were …

Pathologymedicine.medical_specialtyHeart diseasebusiness.industryHypertrophic cardiomyopathyCardiomyopathymedicine.diseaseSudden deathPathology and Forensic MedicineMuscle hypertrophyPathogenesismedicine.anatomical_structureVentriclemedicineDifferential diagnosisbusinessLawForensic Science International
researchProduct

Clinical and Genetic Aspects of Juvenile Onset Pompe Disease

2021

AbstractLittle is known about clinical symptomatology and genetics of juvenile onset Pompe disease (JOPD). The aims of this study were to analyze how these children are diagnosed, what clinical problems they have, and how phenotype is related to genotype. To accomplish this, we analyzed retrospectively data of 34 patients diagnosed after their first and before completion of their 18th birthday. Median age at diagnosis was 3.9 (range 1.1–17) years. Eight patients (23.5%) developed initial symptoms in the first year, 12 (35%) between 1 and 7 years, and 6 (18%) thereafter. Eight (23.5%) had no clinical symptoms at the time of diagnosis. Indications for diagnostics were a positive family histor…

Pediatricsmedicine.medical_specialtyGeneralized muscle weaknessDisease03 medical and health sciences0302 clinical medicineGenotypeHumansMedicineFamily historyRetrospective Studies030304 developmental biology0303 health sciencesGlycogen Storage Disease Type IIbusiness.industryHypertrophic cardiomyopathyMuscle weaknessalpha-GlucosidasesGeneral Medicinemedicine.disease3. Good healthPhenotypeJuvenile onsetMutationPediatrics Perinatology and Child HealthFailure to thriveNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryNeuropediatrics
researchProduct

Declining Incidence of Infantile Hypertrophic Stenosis (IHPS) in Germany 2000-2008

2011

Background: The incidencce of infantile hypertrophic pyloric stenosis (IHPS) is highly variable over time and regionally different. There have been reports of declining incidence in Sweden, the US, Denmark and Scotland. In Sweden, the decline observed was parallel to the declining incidence of Sudden Infant Death Syndrome (SIDS) and was attributed to campaigns against prone sleeping position.

Pediatricsmedicine.medical_specialtyProne sleepingbusiness.industryIncidence (epidemiology)Pediatric researchSudden infant death syndromePediatrics Perinatology and Child HealthEpidemiologymedicineNeonatologyHypertrophic stenosisbusinessHypertrophic Pyloric StenosisPediatric Research
researchProduct

982 Maternal Age, History of Migration and Incidence of Infantile Hypertrophic Pyloric Stenosis in Germany in 2000-2008

2012

Background The incidence of infantile hypertrophic pyloric stenosis (IHPS) is highly variable over time and geographic regions. A decline in IHPS incidence was recently reported in Sweden, the US, Denmark, and Scotland and in Germany. Aim In further evaluation of our previous epidemiological data, we collected data on maternal age and history of migration in mothers from the regional administrations. We examined correlations between these factors and IHPS incidence. Methods Data were extracted from the public report of Health (Gesundheitsberichterstattung des Bundes) and population data from federal state governments. We collected the numbers of IHPS (International Statistical Classificatio…

Pediatricsmedicine.medical_specialtybusiness.industryIncidence (epidemiology)First birthPediatrics Perinatology and Child HealthEpidemiologyPopulation dataMedicineInternational Statistical Classification of Diseases and Related Health ProblemsNegative correlationbusinessHypertrophic Pyloric StenosisFederal stateDemographyArchives of Disease in Childhood
researchProduct